Merck said yesterday that is corrected the study that led to the withdrawal of Vioxx, but that it didn't change the results of the the Approve Study.
Merck said this does not change the Approve results: That use of Vioxx increased the risk of blood clot-related heart attacks after 18 months of continuous treatment.
The source of this article is from Money.com, which you can read by going here.
